We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00347243
First Posted: July 4, 2006
Last Update Posted: October 26, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Federal University of São Paulo
  Purpose
Purpose:To compare visual performance, total and high order wavefront aberrations (coma, spherical aberration and other terms) and contrast sensitivity in eyes implanted with one monofocal aspheric intraocular lens (IOL) and two spherical IOLs (SofPort AO, Soflex,AcrySof®IQ (40 eyes), AcrySof®Natural and AMO®Sensar)

Condition Intervention Phase
Cataract Pseudophakia Procedure: phacoemulsification (cataract surgery) Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical

Resource links provided by NLM:


Further study details as provided by Federal University of São Paulo:

Study Start Date: September 2005
Estimated Study Completion Date: June 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with bilateral visually significant senile cataract, corneal astigmatism less than 2.0 diopters and potential acuity meter (PAM) better than 0.2 LogMar

Exclusion Criteria:

  • any other ocular diseases, such as corneal opacities or irregularity, dry eye, amblyopia, anisometropia, glaucoma, retinal abnormalities, surgical complications, IOL tilt, decentration (estimated by retro illumination and digital photo) greater than 0.4mm13 or loss of follow-up
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347243


Locations
Brazil
Federal University of Sao paulo
Sao Paulo, SP, Brazil, 04044-020
Sponsors and Collaborators
Federal University of São Paulo
Investigators
Study Director: Paulo Schor, MD UNIFESP - EPM
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00347243     History of Changes
Other Study ID Numbers: CEP012/06
First Submitted: June 30, 2006
First Posted: July 4, 2006
Last Update Posted: October 26, 2006
Last Verified: March 2006

Additional relevant MeSH terms:
Cataract
Pseudophakia
Lens Diseases
Eye Diseases
Signs and Symptoms